Literature DB >> 30024790

Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function.

Deok Hwa Nam1, Eunah Kim1, Ashley Benham2, Hye-Kyung Park1, Benjamin Soibam3, George E Taffet4, Jason T Kaelber5,6, Ji Ho Suh1, Heinrich Taegtmeyer7, Mark L Entman4, Erin L Reineke1.   

Abstract

Coordinated changes in signaling pathways and gene expression in hearts subjected to prolonged stress maintain cardiac function. Loss of steroid receptor coactivator-2 (SRC-2) results in a reversal to the fetal gene program and disrupts the response to pressure overload, accompanied by prominent effects on metabolism and growth signaling, including increased AMPK activation. We proposed that early metabolic stress driven by AMPK activation induces contractile dysfunction in mice lacking SRC-2. We used 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) to activate AMPK transiently before transverse aortic constriction (TAC) in wild-type and cardiomyocyte-specific SRC-2 knockout (CKO) animals. In contrast to AMPK activities during stress, in unstressed hearts, AICAR induced a mild activation of Akt signaling, and, in SRC-2-CKO mice, partially relieved an NAD+ deficiency and increased antioxidant signaling. These molecular changes translated to a mild hypertrophic response to TAC with decreased maladaptive remodeling, including markedly decreased fibrosis. Additionally, preactivation of AMPK in SRC-2-CKO mice was accompanied by a dramatic improvement in cardiac function compared with saline-treated SRC-2-CKO mice. Our results show that altered molecular signaling before stress onset has extended effects on sustained cardiac stress responses, and prestress modulation of transient growth and metabolism pathways may control those effects.-Nam, D. H., Kim, E., Benham, A., Park, H.-K., Soibam, B., Taffet, G. E., Kaelber, J. T., Suh, J. H., Taegtmeyer, H., Entman, M. L., Reineke, E. L. Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function.

Entities:  

Keywords:  cardiac metabolism; cardiac stress; fibrosis; heart failure; hypertrophy

Mesh:

Substances:

Year:  2018        PMID: 30024790      PMCID: PMC6355077          DOI: 10.1096/fj.201800602R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  28 in total

1.  Doppler evaluation of peripheral vascular adaptations to transverse aortic banding in mice.

Authors:  Yi-Heng Li; Anilkumar K Reddy; George E Taffet; Lloyd H Michael; Mark L Entman; Craig J Hartley
Journal:  Ultrasound Med Biol       Date:  2003-09       Impact factor: 2.998

Review 2.  AMP-activated protein kinase regulation and biological actions in the heart.

Authors:  Vlad G Zaha; Lawrence H Young
Journal:  Circ Res       Date:  2012-08-31       Impact factor: 17.367

3.  Steroid receptor coactivator-2 (SRC-2) coordinates cardiomyocyte paracrine signaling to promote pressure overload-induced angiogenesis.

Authors:  Ji Ho Suh; Li Lai; Deokhwa Nam; Jong Kim; Juyeon Jo; George E Taffet; Eunah Kim; Jason T Kaelber; Hyun-Kyoung Lee; Mark L Entman; John P Cooke; Erin L Reineke
Journal:  J Biol Chem       Date:  2017-11-10       Impact factor: 5.157

Review 4.  An expanded role for AMP-activated protein kinase: regulator of myocardial protein degradation.

Authors:  Kedryn K Baskin; Heinrich Taegtmeyer
Journal:  Trends Cardiovasc Med       Date:  2011-05       Impact factor: 6.677

5.  Steroid receptor coactivator-2 is a dual regulator of cardiac transcription factor function.

Authors:  Erin L Reineke; Ashley Benham; Benjamin Soibam; Erin Stashi; Heinrich Taegtmeyer; Mark L Entman; Robert J Schwartz; Bert W O'Malley
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

6.  Inhibitory crosstalk between ERK and AMPK in the growth and proliferation of cardiac fibroblasts.

Authors:  Jianhai Du; Tongju Guan; Hui Zhang; Yi Xia; Fei Liu; Youyi Zhang
Journal:  Biochem Biophys Res Commun       Date:  2008-02-01       Impact factor: 3.575

7.  AMPK and PPARdelta agonists are exercise mimetics.

Authors:  Vihang A Narkar; Michael Downes; Ruth T Yu; Emi Embler; Yong-Xu Wang; Ester Banayo; Maria M Mihaylova; Michael C Nelson; Yuhua Zou; Henry Juguilon; Heonjoong Kang; Reuben J Shaw; Ronald M Evans
Journal:  Cell       Date:  2008-07-31       Impact factor: 41.582

8.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

9.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

10.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nucleic Acids Res       Date:  2008-11-25       Impact factor: 16.971

View more
  4 in total

Review 1.  AMPK: a balancer of the renin-angiotensin system.

Authors:  Jia Liu; Xuan Li; Qingguo Lu; Di Ren; Xiaodong Sun; Thomas Rousselle; Ji Li; Jiyan Leng
Journal:  Biosci Rep       Date:  2019-09-03       Impact factor: 3.840

Review 2.  The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.

Authors:  Kerstin N Timm; Damian J Tyler
Journal:  Cardiovasc Drugs Ther       Date:  2020-04       Impact factor: 3.727

3.  ATPase inhibitory factor 1 protects the heart from acute myocardial ischemia/reperfusion injury through activating AMPK signaling pathway.

Authors:  Jia-Wei Wu; Hao Hu; Jin-Sheng Hua; Li-Kun Ma
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 4.  AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review.

Authors:  Dora Višnjić; Hrvoje Lalić; Vilma Dembitz; Barbara Tomić; Tomislav Smoljo
Journal:  Cells       Date:  2021-05-04       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.